These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 29976532
1. Sickle SCAN™ (BioMedomics) fulfills analytical conditions for neonatal screening of sickle cell disease. Nguyen-Khoa T, Mine L, Allaf B, Ribeil JA, Remus C, Stanislas A, Gauthereau V, Enouz S, Kim JS, Yang X, Gluckman E, Beaudeux JL, Munnich A, Girot R, Cavazzana M. Ann Biol Clin (Paris); 2018 Aug 01; 76(4):416-420. PubMed ID: 29976532 [Abstract] [Full Text] [Related]
2. New approach to accurate interpretation of sickle cell disease newborn screening by applying multiple of median cutoffs and ratios. Allaf B, Patin F, Elion J, Couque N. Pediatr Blood Cancer; 2018 Sep 01; 65(9):e27230. PubMed ID: 29781571 [Abstract] [Full Text] [Related]
3. Strategy linking several analytical methods of neonatal screening for sickle cell disease. Ducrocq R, Pascaud O, Bévier A, Finet C, Benkerrou M, Elion J. J Med Screen; 2001 Sep 01; 8(1):8-14. PubMed ID: 11373853 [Abstract] [Full Text] [Related]
4. Validation of a novel point of care testing device for sickle cell disease. Kanter J, Telen MJ, Hoppe C, Roberts CL, Kim JS, Yang X. BMC Med; 2015 Sep 16; 13():225. PubMed ID: 26377572 [Abstract] [Full Text] [Related]
12. Point-of-care screening for sickle cell disease in low-resource settings: A multi-center evaluation of HemoTypeSC, a novel rapid test. Steele C, Sinski A, Asibey J, Hardy-Dessources MD, Elana G, Brennan C, Odame I, Hoppe C, Geisberg M, Serrao E, Quinn CT. Am J Hematol; 2019 Jan 16; 94(1):39-45. PubMed ID: 30290004 [Abstract] [Full Text] [Related]
13. Newborn Screening for Sickle Cell Disease Using Point-of-Care Testing in Low-Income Setting. Alvarez OA, Hustace T, Voltaire M, Mantero A, Liberus U, Saint Fleur R. Pediatrics; 2019 Oct 16; 144(4):. PubMed ID: 31530717 [Abstract] [Full Text] [Related]
14. Newborn blood spot screening for sickle cell disease by using tandem mass spectrometry: implementation of a protocol to identify only the disease states of sickle cell disease. Moat SJ, Rees D, King L, Ifederu A, Harvey K, Hall K, Lloyd G, Morrell C, Hillier S. Clin Chem; 2014 Feb 16; 60(2):373-80. PubMed ID: 24158758 [Abstract] [Full Text] [Related]
16. Multicenter Evaluation of HemoTypeSC as a Point-of-Care Sickle Cell Disease Rapid Diagnostic Test for Newborns and Adults Across India. Mukherjee MB, Colah RB, Mehta PR, Shinde N, Jain D, Desai S, Dave K, Italia Y, Raicha B, Serrao E. Am J Clin Pathol; 2020 Jan 01; 153(1):82-87. PubMed ID: 31433854 [Abstract] [Full Text] [Related]
17. A Paper-Based Test for Screening Newborns for Sickle Cell Disease. Piety NZ, George A, Serrano S, Lanzi MR, Patel PR, Noli MP, Kahan S, Nirenberg D, Camanda JF, Airewele G, Shevkoplyas SS. Sci Rep; 2017 Apr 03; 7():45488. PubMed ID: 28367971 [Abstract] [Full Text] [Related]
20. Point-of-Care Newborn Screening for Sickle Cell Disease at Selected Health Facilities in the Gambia. Adegoke SA, Makalo L, Sallah A, Saine H, Joof S, Conteh A, Bah R, Camara Jammeh AF, Bass M, Jallow M, Nnodu OE. Hemoglobin; 2024 May 03; 48(3):169-174. PubMed ID: 38980121 [Abstract] [Full Text] [Related] Page: [Next] [New Search]